Extended Data Fig. 1: Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT) Schema. | Nature Medicine

Extended Data Fig. 1: Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT) Schema.

From: Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

Extended Data Fig. 1: Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT) Schema.

ATTEMPT is a multi-center, double blind, randomized, placebo-controlled trial designed to evaluate the effect of treatment with Dapagliflozin when compared to placebo, in combination with adjustable insulin, on measured GFR and HbA1c in adolescents with T1D over a 22-week evaluation period (16-week treatment period) to test the hypotheses that treatment with dapagliflozin, in combination with adjustable insulin, will reduce mean measured GFR and HbA1c when compared with placebo.

Back to article page